• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC GUARDWIRE TEMPORARY OCCLUSION SYSTEM; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC GUARDWIRE TEMPORARY OCCLUSION SYSTEM; CATHETER, EMBOLECTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Transient Ischemic Attack (2109); Embolism/Embolus (4438)
Event Date 01/07/2021
Event Type  Injury  
Manufacturer Narrative
Journal article: efficacy of pretreatment with the free radical scavenger, edaravone, for prevention of cerebral hyperperfusion after carotid artery stenting: a single-center randomized controlled trial.Journal: interdisciplinary neurosurgery: advanced techniques and case year: 2021 ref: doi.Org/10.1016/j.Inat.2021.101092.Patient age: average age.Sex: majority gender.Event date: date of publication.
 
Event Description
A journal article titled - efficacy of pretreatment with the free radical scavenger, edaravone, for prevention of cerebral hyperperfusion after carotid artery stenting: a single-center randomized controlled trial - was submitted for review.This is a randomized controlled trial (rct) of 51 patients which aimed to evaluate whether pre-treatment with a free radical scavenger, edaravone, can prevent cerebral hyperperfusion (chp) after carotid artery stenting (cas).The medtronic guardwire embolic protection device was among the devices used during the procedures for distal protection.One patient experienced an embolic complication during cas and could not be included in the trial.Perioperative complications occurred in 3 patients: 2 had ischemic stroke or transient ischemic attack, and one patient had retroperitoneal hemorrhage caused by femoral artery puncture site bleeding.Of the 51 patients, 3 had chp, including one with transient postprocedural hypotension.The trial was stopped ahead of schedule due to poor recruitment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GUARDWIRE TEMPORARY OCCLUSION SYSTEM
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
MEDTRONIC, INC
37a cherry hill dr
danvers MA 01923
Manufacturer (Section G)
MEDTRONIC, INC
37a cherry hill dr
danvers MA 01923
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12231670
MDR Text Key264275736
Report Number1220452-2021-00029
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K023878
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 07/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/09/2021
Initial Date FDA Received07/27/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age73 YR
-
-